Intelligence / Healthtech / De Novo Grants / Neurovalens Limited
Approvalsnovel device granted (FDA De Novo)17 Oct 2025
Neurovalens Limited
17 Oct 2025: Novel device granted (FDA De Novo) · Modius Lean. Recorded in the openFDA device 510(k) (De Novo decisions).
- Granted
- 17 Oct 2025
- Device
- Modius Lean
- Specialty
- Gastroenterology, Urology
- Product Code
- SFW
- Country
- United Kingdom
- Location
- Portglenone, United Kingdom
- Submitted
- 2024-12-18
- Reference
- DEN240076
What this signal means
A De Novo grant creates a new device category: reimbursement coding, distribution, clinical evidence, manufacturing scale-up and sales hires follow.
- 2 added in the 30 days to 19 Nov 2026.
- Neurology leads (10); 29% went to makers outside the US.
Reach them with AOS
Find the decision makers at Neurovalens Limited
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Across AOS Research
Other records for Neurovalens Limited in our registers.
More in Gastroenterology, Urology
De Novo Grants
20 AugCm Technologies, Inc.novel device granted (FDA De Novo) · Qoramatic Automated Stool ManagementApprovals30 AprCathbuddy, Inc.novel device granted (FDA De Novo) · Aurie SystemApprovals15 JanBridge TO Life, Ltd.novel device granted (FDA De Novo) · VitaSmart Hypothermic Oxygenated Perfusion SystemApprovals
Source: openFDA device 510(k) (De Novo decisions), data to 19 Nov 2026. Every De Novo classification FDA granted in the last 24 months: a novel device with no legally marketed predicate, which creates a new device type and product code. AOS shows what the public record says; it does not verify or endorse the company.